# Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ – FDA Inspections

Source: https://www.keypedia.com/companies/otsuka-pharmaceutical-development-commercialization-inc/a1427d0e-e216-46ba-9158-bc52701a7a70

> Inspection records and compliance data for Otsuka Pharmaceutical Development & Commercialization, Inc. in Princeton, New Jersey. 3 FDA inspections on record, last inspected June 25, 2025.

---

## Details

- Name: Otsuka Pharmaceutical Development & Commercialization, Inc.
- FEI Number: 3010447004
- Address Line 1: 508 Carnegie Ctr
- City: Princeton
- State: New Jersey
- Zip Code: 08540
- Country Name: United States
- Address: 508 Carnegie Ctr, Princeton, New Jersey 08540, United States
- Country: United States

## Related Documents

- FDA Inspection 1276733 - Otsuka Pharmaceutical Development & Commercialization, Inc. - 2025-06-25 — source: FDA, date: June 25, 2025
- FDA Inspection 1276733 - Otsuka Pharmaceutical Development & Commercialization, Inc. - 2025-06-25 — classification: No Action Indicated (NAI), source: FDA, date: June 25, 2025
- [FDA Inspection 1276733 - Otsuka Pharmaceutical Development & Commercialization, Inc. - 2025-06-25](https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-development-commercialization-inc/f511ad3b-3616-4cda-bc99-e643315dc9a0) — classification: No Action Indicated (NAI), source: FDA, date: June 25, 2025
- FDA Inspection 1001627 - Otsuka Pharmaceutical Development & Commercialization, Inc. - 2017-02-03 — classification: No Action Indicated (NAI), source: FDA, date: February 3, 2017
- [FDA Inspection 868761 - Otsuka Pharmaceutical Development & Commercialization, Inc. - 2014-03-18](https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-development-commercialization-inc/4ae736dc-c8ef-478e-819a-5439f8e8e120) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 18, 2014

## Related Companies

- [RECORDATI RARE DISEASES INC.](https://www.keypedia.com/companies/recordati-rare-diseases-inc/fe4d8433-7b37-493d-9f5d-33e09b56d6b0)
- [Bruce E. Silverstein, M.D.](https://www.keypedia.com/companies/bruce-e-silverstein-md/6194607c-a8d5-4116-a0b7-66f82fefd848)
- [Batelle Corporate Operations IRB](https://www.keypedia.com/companies/batelle-corporate-operations-irb/2d635497-d73e-49c5-ab05-4fe130deae56)
- [University Hospitals Cleveland Medical Center IRB](https://www.keypedia.com/companies/university-hospitals-cleveland-medical-center-irb/e78c4230-2786-4425-9ad7-f5e431913efd)
- [3M COMPANY](https://www.keypedia.com/companies/3m-company/999d0f59-ffb0-48ec-8825-7d5ce4070dc3)
- [Harry J Bosworth Company](https://www.keypedia.com/companies/harry-j-bosworth-company/834a2215-8438-4b2a-8de0-91e84ce1e23f)
- [Bioserv Corporation](https://www.keypedia.com/companies/bioserv-corporation/1d9b6bef-b61b-40ae-8d76-978a820dd6dc)
- [Jeffrey H. Levenson, MD](https://www.keypedia.com/companies/jeffrey-h-levenson-md/43b633ee-888c-488a-a420-36409fa6d0f8)
- [Criner,Gerard J Md](https://www.keypedia.com/companies/crinergerard-j-md/e6372303-0382-41a2-8bc9-b70a31422072)
- [Cramer Products Inc](https://www.keypedia.com/companies/cramer-products-inc/d7e7fa6d-0836-47a2-9d5f-a59def20b4e7)